These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13492945)

  • 1. [Preliminary report on oral honvan therapy of prostate carcinoma].
    WARNECKE CE
    Medizinische; 1957 Nov; 25(44):1625-7. PubMed ID: 13492945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with Honvan therapy in carcinoma of the prostate].
    Joó GD
    Med Welt; 1966 Jan; 1():61-4. PubMed ID: 5942368
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Treatment of carcinoma of the prostate by continuous infusion of stilboestrol diphosphate (Honvan).
    Heap G
    Br J Urol; 1976 Apr; 48(2):152-3. PubMed ID: 953436
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in treating metastic carcinoma of prostate with honvan (''ST 52-ASTA'')].
    ROCKSTROH H
    Z Urol; 1955; 48(11):720-30. PubMed ID: 13300707
    [No Abstract]   [Full Text] [Related]  

  • 5. Diethylstitboestrol in the treatment of inoperable carcinoma of the prostate: a preliminary report.
    MACKINNON KJ; NEARING TN; CARRUTHERS NC
    Can Med Assoc J; 1957 Dec; 77(11):1009-12. PubMed ID: 13489589
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution to the honvan treatment of prostatic carcinoma].
    FULAR W
    Medizinische; 1956 Feb; (8):285-8. PubMed ID: 13321398
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of prostate carcinoma with transurethral infiltrations of phosphorylated diethylstibesterol; preliminary report].
    ROTHAUGE CF
    Arztl Wochensch; 1958 Mar; 13(11):233-5. PubMed ID: 13533095
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal insufficiency caused by a "silent" prostatic carcinoma, successfully treated by di-ethyl-di-oxy-stilbene (Honvan) and temporary haemodialysis.
    Dekema H; Oomen H
    Folia Med Neerl; 1972; 15(3):161-6. PubMed ID: 5041599
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the mechanism of action of stilbestrol diphosphate (honvan) in prostate carcinoma].
    DRUCKREY H; BROCK N
    Munch Med Wochenschr; 1960 Aug; 102():1626-9. PubMed ID: 13724501
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen therapy in carcinoma of the prostate.
    BIRKE G; FRANKSSON C; PLANTIN LO
    Acta Chir Scand; 1955 Apr; 109(1):1-10. PubMed ID: 14387447
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostatic cancer and its prognosis under Honvan treatment].
    Gaca A; Köhnlein HE; Köttgen H
    Med Welt; 1968 Apr; 15():961-7. PubMed ID: 5717752
    [No Abstract]   [Full Text] [Related]  

  • 12. Mammary neoplasm in a male receiving oestrogen therapy for carcinoma of the prostate.
    MOULTON JE
    Med J Aust; 1959 May; 1(21):706-7. PubMed ID: 13666165
    [No Abstract]   [Full Text] [Related]  

  • 13. Diethylstilboestrol diphosphate, honvan (ST 52-asta), in intravenous tumour-specific chemotherapy of metastatic carcinoma of the prostate.
    HANSEN CC
    Acta Chir Scand; 1958 Apr; 114(5):398-413. PubMed ID: 13532319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vascular lesions following long-term treatment with Honvan].
    Druckrey H
    Munch Med Wochenschr; 1971 Oct; 113(44):1475-7. PubMed ID: 5001655
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liver function tests during honvan therapy of prostatic carcinoma].
    Ueberle W; Ludwig G; Peters HJ
    Med Welt; 1973 Jun; 24(22):939-41. PubMed ID: 4748014
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative studies on the side-effects of estrogen therapy in the use of various types of hormones in patients with prostate carcinoma & adenoma].
    TAUPITZ A
    Medizinische; 1959 May; 4(18):873-6. PubMed ID: 13656334
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary cancer of the lung of prostatic origin; recovery maintained for 3 years by diethylstilbestrol therapy].
    MEYER A; LIOT F
    Bull Mem Soc Med Hop Paris; 1954 Mar 26-Apr 9; 70(11-12):401-4. PubMed ID: 13172629
    [No Abstract]   [Full Text] [Related]  

  • 18. Planned cytostatic therapy of carcinoma of the prostate.
    WARNECKE CE
    Bruns Beitr Klin Chir; 1955 May; 190(3):341-8. PubMed ID: 14389781
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of conservative therapy in prostate carcinoma].
    PAGEL W
    Z Urol; 1957; 50(12):681-8. PubMed ID: 13531567
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of stilbo-estrol phosphate in prostate carcinoma].
    HOHLWEG W; GROOT-WASSINK KA
    Dtsch Gesundheitsw; 1959 Jan; 14(4):152-7. PubMed ID: 13639631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.